Share Email Print

Proceedings Paper

Some attempts for improvement of balloon laserthermia
Author(s): Koichi Futatsuki; Koji Saifuku; Kunio Yamamoto; Nobuyuki Takeuchi; Yuzoh Kanda; Tositaka Uehara; Yoshio Sekiguchi
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

We investigated the use of a new Nd:YAG laser irradiation method, 'balloon laserthermia' I involving use of a balloon filled with a light diffusing substance attached to the end of a quartz fiber. This balloon laserthermia technique, using a 3cm diameter balloon containing 0.25% Intralipid solution, was tested on a Meth-A sarcoma in Balb-C mice. A 20 minute irradiation at 20 watts resulted in the following necrosis rates: control group -4%; 40.0-40.5°C. 35%; 42.5-62%; 50.0 -50.5°C. - 97%. When the balloon size was reduced from 3 to 2cm, the optimum values for hypertherinia were a 0.5% Intralipid solution density and a laser power output of 10 watts. As previous use of balloon laserthermia has generally involved use of quartz fibers with a standard 8° angle of light emission, these experiments included trials of a fiber with a 40°light emission angle, along with various combinations of solution densities and laser output conditions. When used with 0.25% Intralipid I the wide-angle fiber provided a power density distribution around the balloon equivalent to that of the standard fiber, but with only half the laser output for hyperthermia, about 10 watts.

Paper Details

Date Published: 1 July 1990
PDF: 12 pages
Proc. SPIE 1201, Optical Fibers in Medicine V, (1 July 1990); doi: 10.1117/12.17598
Show Author Affiliations
Koichi Futatsuki, Saitama Cancer Ctr. (Japan)
Koji Saifuku, Saitama Cancer Ctr. (Japan)
Kunio Yamamoto, Saitama Cancer Ctr. (Japan)
Nobuyuki Takeuchi, Saitama Cancer Ctr. (Japan)
Yuzoh Kanda, Saitama Cancer Ctr. (Japan)
Tositaka Uehara, Saitama Cancer Ctr. (Japan)
Yoshio Sekiguchi, Surgical Laser Technologies Co., Ltd. (Japan)

Published in SPIE Proceedings Vol. 1201:
Optical Fibers in Medicine V
Abraham Katzir, Editor(s)

© SPIE. Terms of Use
Back to Top